SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsArchive2026-11-03

Tue, Nov 03, 2026 - Page 43

26428 indexed SquawkNews stories from this UTC day. Showing 5041-5160.

EQUITY 18136EARNINGS 2896MACRO 1089REGULATION 1015GEOPOLITICS 575MNA 522ENERGY 507RATES 361COMMODITIES 333NEWS 328FX 249CENTRAL_BANK 222
M Greif Reports Q4 Adjusted EPS of $0.87 per Share Greif’s Q4 adjusted EPS was $0.87, versus a FactSet estimate of $1.16. EARNINGS | Nov 03, 2026, 09:05 PM UTC L Bowhead Specialty Holdings files Form 10-Q for quarter ended September 30 Bowhead Specialty Holdings filed its Form 10-Q on November 3. EQUITY | Nov 03, 2026, 09:05 PM UTC M AtriCure Q3 Revenue Reaches $154.5 Million AtriCure reported Q3 revenue of $154.5 million versus an IBES estimate of $151.2 million. EQUITY | Nov 03, 2026, 09:05 PM UTC L Douglas Dynamics files Form 10-Q for quarter ended Sept. 30 EQUITY | Nov 03, 2026, 09:05 PM UTC M Globus Medical Acquires Synaptive Medical EQUITY | Nov 03, 2026, 09:05 PM UTC M Huron Consulting Reports Third-Quarter Net Income of $28.4M EARNINGS | Nov 03, 2026, 09:05 PM UTC L Brunswick Corp. Form 4 Filed by Joseph W. McClanathan A Form 4 for Brunswick Corp. covering Oct. 30 was filed Nov. 3. EQUITY | Nov 03, 2026, 09:05 PM UTC L Octagon Capital Advisors Files Schedule 13G/A for Precision BioSciences Octagon Capital Advisors LP filed a Schedule 13G/A for Precision BioSciences. The filing date is listed as November 3, 20. EQUITY | Nov 03, 2026, 09:05 PM UTC L Bank of Nova Scotia files Form 424B2 EQUITY | Nov 03, 2026, 09:05 PM UTC M QuidelOrtho reports a third-quarter loss per share EQUITY | Nov 03, 2026, 09:05 PM UTC L Kforce Form 4 Filed by David L. Dunkel A Form 4 for Kforce Inc. was filed by David L. Dunkel for October 30. The filing date is November 3. EQUITY | Nov 03, 2026, 09:05 PM UTC M PayPay Sets FY2027 Revenue Outlook at ¥474,000M–¥478,000M EARNINGS | Nov 03, 2026, 09:05 PM UTC L Brunswick Corp. Form 4 Filed by Roger Wood A Form 4 for Roger Wood covering October 30 was filed November 3. EQUITY | Nov 03, 2026, 09:05 PM UTC L Nurix Therapeutics files Form 8-K Nurix Therapeutics filed a Form 8-K on November 3. EQUITY | Nov 03, 2026, 09:05 PM UTC M Nurix Says Sanofi Halts Phase 1 Trial of STAT6 Degrader SAR448272 EQUITY | Nov 03, 2026, 09:05 PM UTC L Spyre Therapeutics Reports Q3 Net Income Below IBES Estimate Q3 net income was below the IBES estimate. EARNINGS | Nov 03, 2026, 09:05 PM UTC L Valiente Receives Conditional TSX Venture Exchange Listing Approval Valiente has received conditional approval from the TSX Venture Exchange to list its shares. EQUITY | Nov 03, 2026, 09:05 PM UTC M Coupang Announces Third-Quarter 2026 Results Coupang announced results for the quarter ended September 30, 2026. The supplied text contains no financial figures. EQUITY | Nov 03, 2026, 09:05 PM UTC L eGain SVP Reports Sale of 6,000 Common Shares for $35,421 eGain SVP of Products and Services Chandrasekhar Rao Jadcherla reported selling 6,000 common shares for $35,421. EQUITY | Nov 03, 2026, 09:05 PM UTC L Nasdaq rises as AI stocks rebound ahead of US midterms US stocks closed higher, led by a Nasdaq rise as AI stocks rebounded. The closing figures were provisional. EQUITY | Nov 03, 2026, 09:05 PM UTC L TPG Inc. files Form 10-Q for quarter ended September 30 TPG Inc. filed a Form 10-Q for the period ended September 30. EQUITY | Nov 03, 2026, 09:05 PM UTC M Block Posts Third-Quarter 2026 Results Block posted its third-quarter 2026 results on its investor relations website and will hold a conference call and webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). EQUITY | Nov 03, 2026, 09:05 PM UTC L Brunswick Form 4 Filed by David C. Everitt for Oct. 30 A Form 4 for Brunswick Corp. was filed by David C. Everitt on Nov. 3. EQUITY | Nov 03, 2026, 09:05 PM UTC L Aura Biosciences to Participate in Upcoming Investor Conference EQUITY | Nov 03, 2026, 09:05 PM UTC L Spyre Therapeutics files Form 8-K Spyre Therapeutics filed a Form 8-K on November 3. EQUITY | Nov 03, 2026, 09:05 PM UTC M Evertec reports third-quarter EPS EARNINGS | Nov 03, 2026, 09:05 PM UTC L Premium Global Income Split Fund Declares Monthly Distribution EQUITY | Nov 03, 2026, 09:05 PM UTC L Evertec reports third-quarter net income of $29.9 million EARNINGS | Nov 03, 2026, 09:05 PM UTC M Andersons Reports Third-Quarter Net Income of $46.4M EARNINGS | Nov 03, 2026, 09:05 PM UTC L Astec Industries Director Knoll to Resign; Keating Appointed to Board Linda Knoll will leave Astec Industries’ Board and its committees. John Keating has been appointed to the Board and Audit Committee. EQUITY | Nov 03, 2026, 09:05 PM UTC L Zebra Technologies files Form 10-Q Zebra Technologies filed a Form 10-Q for Oct. 3. EQUITY | Nov 03, 2026, 09:05 PM UTC L First Acceptance Reports Results for Three and Nine Months Ended September 30, 2026 EARNINGS | Nov 03, 2026, 09:05 PM UTC L Premium Income Corporation Announces Monthly Distribution EQUITY | Nov 03, 2026, 09:05 PM UTC L Mercury Systems Elects Three Class II Directors Mercury Systems elected Jean Bua, Gerard J. DeMuro and Scott Ostfeld as Class II directors for three-year terms ending in 2029. EQUITY | Nov 03, 2026, 09:05 PM UTC M Greif Reports Q4 Net Income of USD -3.2 Million EARNINGS | Nov 03, 2026, 09:05 PM UTC M PayPay Q2 Profit Falls 75% to ¥18.44 Billion EQUITY | Nov 03, 2026, 09:05 PM UTC L Monolithic Power Systems Files Form 10-Q for Quarter Ended Sept. 30 Monolithic Power Systems filed a Form 10-Q for the period ended Sept. 30. EQUITY | Nov 03, 2026, 09:05 PM UTC L Brunswick Form 4 Filed by J. Steven Whisler for Oct. 30 A Form 4 for Brunswick Corp. was filed on November 3. EQUITY | Nov 03, 2026, 09:05 PM UTC L Brunswick Corp. Form 4 Filed by MaryAnn Wright A Form 4 for Brunswick Corp. covering Oct. 30 was filed Nov. 3. EQUITY | Nov 03, 2026, 09:05 PM UTC L Interface Inc. Form 4 Filed by Daniel T. Hendrix A Form 4 for Interface Inc. was filed by Daniel T. Hendrix for Nov. 2. EQUITY | Nov 03, 2026, 09:05 PM UTC L Key Tronic Reports Q1 Gross Margin of 2.5% EARNINGS | Nov 03, 2026, 09:04 PM UTC M FLINT reports Q3 revenue of CAD 267.215 million EQUITY | Nov 03, 2026, 09:04 PM UTC M Nurix Therapeutics Will Receive No Future SAR448272 Milestones or Royalties EQUITY | Nov 03, 2026, 09:04 PM UTC M Manitowoc Q3 Gross Profit $121.8 Million EQUITY | Nov 03, 2026, 09:04 PM UTC L Robo.ai Reaffirms Approved 1-for-25 Reverse Stock Split Robo.ai said it reaffirmed its previously announced and approved 1-for-25 reverse split of all classes of its ordinary shares. EQUITY | Nov 03, 2026, 09:04 PM UTC L Amgen issues full-year adjusted EPS outlook EARNINGS | Nov 03, 2026, 09:04 PM UTC L Gladstone Commercial files Form 10-Q for quarter ended September 30 EQUITY | Nov 03, 2026, 09:04 PM UTC L Archer-Daniels-Midland files Form 10-Q for quarter ended Sept. 30 Archer-Daniels-Midland filed a Form 10-Q for the period ended Sept. 30. EQUITY | Nov 03, 2026, 09:04 PM UTC L S&P Global Form 4 Filed for Thomas Darren Robert A Form 4 for S&P Global Inc. was filed for Nov. 1; the filing date is listed as Nov. 3. EQUITY | Nov 03, 2026, 09:04 PM UTC L Brunswick Form 4 Filed by Reginald Fils-Aime for Oct. 30 A Form 4 for Brunswick Corp. was filed by Reginald Fils-Aime. The filing date is listed as November 3. EQUITY | Nov 03, 2026, 09:04 PM UTC L Brunswick Form 4 Filed for David V. Singer A Form 4 for Brunswick Corp. was filed for David V. Singer, covering October 30. The filing date is November 3. EQUITY | Nov 03, 2026, 09:04 PM UTC M Amgen Reports Third-Quarter Revenue of $10.37 Billion EQUITY | Nov 03, 2026, 09:04 PM UTC L Brunswick Form 4 Filed by Nancy E. Cooper A Form 4 for Brunswick Corp. covering October 30 was filed November 3. EQUITY | Nov 03, 2026, 09:04 PM UTC L Mercury Systems files Form 8-K Mercury Systems filed a Form 8-K on November 3. The filing covers October 28. EQUITY | Nov 03, 2026, 09:04 PM UTC L Sanofi Discontinues Development of Nurix STAT6 Degrader SAR448272 Nurix Therapeutics says Sanofi has decided to discontinue development of the STAT6 degrader SAR448272. EQUITY | Nov 03, 2026, 09:04 PM UTC M Skyworks gives Q1 revenue outlook Skyworks' Q1 revenue outlook is USD 1,800-1,900 million. EQUITY | Nov 03, 2026, 09:04 PM UTC L Salamander Innisbrook files Form 8-K Salamander Innisbrook filed a Form 8-K for Oct. 28, according to the alert. EQUITY | Nov 03, 2026, 09:04 PM UTC L Pinterest Form 144 filed by Benjamin Silbermann A Form 144 for Pinterest was filed by Benjamin Silbermann. EQUITY | Nov 03, 2026, 09:04 PM UTC L Aura Biosciences to Participate in Upcoming Investor Conference EQUITY | Nov 03, 2026, 09:04 PM UTC L Ramaco Resources files Form 8-K Ramaco Resources filed a Form 8-K on November 3. EQUITY | Nov 03, 2026, 09:04 PM UTC M Transcat Q2 Adjusted EBITDA Rises to $14.9 Million Transcat reported Q2 adjusted EBITDA of $14.9 million, versus the IBES estimate of $13.3 million. EARNINGS | Nov 03, 2026, 09:04 PM UTC L Nurix Says Sanofi Will Discontinue Development of STAT6 Degrader SAR448272 Nurix Therapeutics announced Sanofi’s decision to discontinue development of the STAT6 degrader SAR448272. EQUITY | Nov 03, 2026, 09:04 PM UTC M Skyworks forecasts Q1 adjusted EPS of $1.25 vs. IBES estimate of $1.50 EARNINGS | Nov 03, 2026, 09:04 PM UTC M Spyre Therapeutics Reports Q3 Operating Loss Q3 income from operations was below the IBES estimate. EQUITY | Nov 03, 2026, 09:04 PM UTC L Monte Rosa Therapeutics Grants Equity Awards to Four New Employees EQUITY | Nov 03, 2026, 09:04 PM UTC H Amgen earnings above expectations at 6.45 USD Amgen (AMGN) released earnings per share at 6.45 USD, compared to market expectations of 5.76 USD. EARNINGS | Nov 03, 2026, 09:04 PM UTC M Trump’s DOJ Sends Monitors Mostly to Democratic Areas, Expands Alaska Probe The Justice Department sent election monitors overwhelmingly to Democratic areas and expanded its Alaska probe. REGULATION | Nov 03, 2026, 09:04 PM UTC M Greif Reports Q4 Operating Profit of USD 36.4 Million EQUITY | Nov 03, 2026, 09:04 PM UTC M Greif Reports Q4 Gross Profit of USD 254.6 Million EQUITY | Nov 03, 2026, 09:04 PM UTC L SSR Mining files Form 10-Q for September 30 SSR Mining filed a Form 10-Q covering the period ended September 30. EQUITY | Nov 03, 2026, 09:04 PM UTC L Skyworks reports Q4 EPS of $0.15 EARNINGS | Nov 03, 2026, 09:04 PM UTC L Gix Internet files Form 6-K Gix Internet filed a Form 6-K on November 3. EQUITY | Nov 03, 2026, 09:04 PM UTC L Affirm Form 4 Filed by Jiyane Siphelele A Form 4 for Affirm Holdings was filed on November 3, covering November 2. EQUITY | Nov 03, 2026, 09:04 PM UTC L BETA Technologies Insider Files Form 144 Clark Kyle filed a Form 144 for BETA Technologies. The supplied filing date is incomplete. EQUITY | Nov 03, 2026, 09:04 PM UTC L Astec Industries files Form 8-K for Oct. 29 Astec Industries filed a Form 8-K on November 3; the filing is dated Oct. 29. EQUITY | Nov 03, 2026, 09:04 PM UTC L Flywire files Form 8-K Flywire filed a Form 8-K on November 3. EQUITY | Nov 03, 2026, 09:04 PM UTC L Crexendo files Form 8-K Crexendo filed a Form 8-K on November 3. EQUITY | Nov 03, 2026, 09:04 PM UTC L ORIC Pharmaceuticals to Participate in Investor Conferences EQUITY | Nov 03, 2026, 09:04 PM UTC L Amphenol Form 4 Filed by Richard Adam Norwitt A Form 4 for Amphenol Corp. was filed by Richard Adam Norwitt for Nov. 2. EQUITY | Nov 03, 2026, 09:03 PM UTC L Flywire Reports Q3 Net Income of USD 74.5 Million EARNINGS | Nov 03, 2026, 09:03 PM UTC L Transcat Reports Q2 EPS of USD 0.25 EARNINGS | Nov 03, 2026, 09:03 PM UTC L Manitowoc Reports Q3 Adjusted EBITDA of $47.4 Million EARNINGS | Nov 03, 2026, 09:03 PM UTC M Denali Therapeutics Reports Third-Quarter 2026 Results Denali Therapeutics reported third-quarter 2026 financial results and business highlights; no figures or details were provided. EQUITY | Nov 03, 2026, 09:03 PM UTC M Flywire Q3 Gross Profit $152.7 Million EQUITY | Nov 03, 2026, 09:03 PM UTC M Key Tronic Reports Q1 Sales of $98.676 Million EARNINGS | Nov 03, 2026, 09:03 PM UTC L Denali Therapeutics Reports Q3 Operating Expenses of $144.529 Million EQUITY | Nov 03, 2026, 09:03 PM UTC L AtriCure Q3 Gross Margin 77.3% EARNINGS | Nov 03, 2026, 09:03 PM UTC M S&T Bancorp Reports Record Third-Quarter EPS of $1.09 S&T Bancorp reported diluted EPS of $1.09 for third-quarter 2026, up 6.9% from the prior quarter, in an investor presentation furnished with an 8-K. EARNINGS | Nov 03, 2026, 09:03 PM UTC L Revolve Group reports third-quarter EPS EARNINGS | Nov 03, 2026, 09:03 PM UTC M Reed’s Raises $10 Million in Share Placement to Majority Stockholder Reed’s agreed to sell 17,421,602 common shares to D&D Source of Life Holding for approximately $10.0 million at $0.574 per share. The placement is expected to close on or about November 6, 2026. EQUITY | Nov 03, 2026, 09:03 PM UTC L Fannie Mae Director Omeed Malik Resigns From Board Omeed Malik resigned from Fannie Mae’s Board of Directors, effective October 30, 2026. EQUITY | Nov 03, 2026, 09:03 PM UTC M Ultragenyx Reports Third-Quarter 2026 Results, Cuts Expenses, Reaffirms 2027 Profitability Ultragenyx reports third-quarter 2026 financial results, announces substantial expense reductions and reaffirms profitability in 2027. EQUITY | Nov 03, 2026, 09:03 PM UTC L Ardelyx reports Q3 operating income of $4.023 million EARNINGS | Nov 03, 2026, 09:03 PM UTC L Flywire Director Alex Finkelstein Resigns From Board Alex Finkelstein resigned from Flywire’s board effective immediately. The company said there was no dispute or disagreement. EQUITY | Nov 03, 2026, 09:03 PM UTC L Sanofi to End Nurix’s SAR448272 Program After Phase 1 Trial Nurix Therapeutics said Sanofi will discontinue the Phase 1 trial and terminate the program, ending potential payments tied to it. EQUITY | Nov 03, 2026, 09:03 PM UTC M Ultragenyx reports Q3 net loss EQUITY | Nov 03, 2026, 09:03 PM UTC L SLR Investment reports quarter ended September 30, 2026 results EARNINGS | Nov 03, 2026, 09:03 PM UTC M Chemung Financial Reports Q3 2026 Net Income of $12.7 Million Chemung Financial reported third-quarter 2026 net income of $12.7 million. The company will discuss its strategy and performance with investors during the fourth quarter. EQUITY | Nov 03, 2026, 09:03 PM UTC L Key Tronic Reports Q1 EPS of USD -0.69 EARNINGS | Nov 03, 2026, 09:03 PM UTC M AtriCure Reports Q3 Operating Income of $4.4 Million EARNINGS | Nov 03, 2026, 09:03 PM UTC L FLINT Reports Q3 Gross Margin of 8.4% EARNINGS | Nov 03, 2026, 09:03 PM UTC L Mirum Pharmaceuticals Reports Q3 Operating Expenses of $245.467 Million EARNINGS | Nov 03, 2026, 09:03 PM UTC L Air Water Ventures Form 4 Filed for November 1 A Form 4 for Air Water Ventures Ltd, filed by David Timothy Tuerff, was reported November 3. EQUITY | Nov 03, 2026, 09:03 PM UTC L Red Rock Resorts files Form 8-K Red Rock Resorts filed a Form 8-K on November 3. EQUITY | Nov 03, 2026, 09:03 PM UTC L Spyre Therapeutics Files Form 10-Q Spyre Therapeutics filed a Form 10-Q for the period ended September 30. EQUITY | Nov 03, 2026, 09:03 PM UTC M AtriCure Reports Q3 Revenue of $154.4 Million Q3 revenue was $154.4 million, compared with a FactSet estimate of $151.1 million. EQUITY | Nov 03, 2026, 09:03 PM UTC M Crexendo Reports Q3 Revenue of USD 25.2 Million Q3 revenue was USD 25.2 million, compared with an IBES estimate of USD 25.1 million. EQUITY | Nov 03, 2026, 09:03 PM UTC L SLR Investment Corp. Announces Results for Quarter Ended September 30, 2026 EARNINGS | Nov 03, 2026, 09:03 PM UTC M Revolve Group reports third-quarter net income of $14.5 million EARNINGS | Nov 03, 2026, 09:03 PM UTC L Mirum Pharmaceuticals reports Q3 EPS of USD -0.87 EARNINGS | Nov 03, 2026, 09:03 PM UTC M Amgen Third-Quarter Sales Rise 8% on Cholesterol and Cancer Drug Demand Amgen said third-quarter sales rose 8%, led by demand for Repatha, Imdelltra and Uplizna. EARNINGS | Nov 03, 2026, 09:02 PM UTC M Greif Reports Fourth-Quarter and Fiscal 2026 Results EQUITY | Nov 03, 2026, 09:02 PM UTC L United Fire Group Q3 expense ratio 34.9% EARNINGS | Nov 03, 2026, 09:02 PM UTC M Red Rock Resorts reports Q3 pretax profit EQUITY | Nov 03, 2026, 09:02 PM UTC L S.H.N. Financial Investments Files Schedule 13D/A for PRF Technologies A Schedule 13D/A beneficial ownership filing for PRF Technologies was filed by S.H.N. Financial Investments Ltd. EQUITY | Nov 03, 2026, 09:02 PM UTC L FLINT reports Q3 EPS of CAD 0.07 FLINT reported Q3 gross profit of CAD 22.565 million. EARNINGS | Nov 03, 2026, 09:02 PM UTC M Ardelyx Reports Q3 Product Sales of $125.455 Million EQUITY | Nov 03, 2026, 09:02 PM UTC M Key Tronic reports Q1 EPS loss Key Tronic reported Q1 net income of USD -7.501 million. EQUITY | Nov 03, 2026, 09:02 PM UTC M Skyworks reports fourth-quarter adjusted EPS of $1.28 EARNINGS | Nov 03, 2026, 09:02 PM UTC M Skyworks Q4 Revenue Reaches USD 1,046 Million Skyworks reported Q4 revenue of USD 1,046 million, compared with an IBES estimate of USD 1,036 million. EQUITY | Nov 03, 2026, 09:02 PM UTC